Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

RECCE PHARMACEUTICALS LTD

INVESTOR PRESENTATION - RECCE PHARMACEUTICALS LTD

ASX:RCE

RECCE PHARMACEUTICALS LTD

Financials

Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of antibiotics. RCE's portfolio of antibiotic therapies seek to address health threats posed by drug resistant bacteria. Their lead candidate RECCE®327 is designed as abroad-spectrum antibiotic, formulated using synthetic polymer technology to treat bacterial sepsis (blood poisoning) and other bacterial infections, including superbugs.

Read more

Market Cap

$203.15m

Price at Close

$1.17

4w avg. Volume

24.73k

4w avg. Turnover

$28.49k

Announcements
announcementt+2 movementdate
  • Results of Meeting

    Notice Of Meeting

  • -

    29 Nov 2020

-

29 Nov 2020
  • RCE AGM Presentation

    Periodic Reports

  • -

    29 Nov 2020

-

29 Nov 2020
Market Data

Current Price

$1.17

52WK HIGH

$1.18

52WK LOW

$1.1

1YR RETURN

+2.18%

1YR RETURN VS. SECTOR

+1.99%

90 DAY RETURN

+2.18%

ASX RANK

585

/2,030

SECTOR RANK

7

/30

SHARES OUTSTANDING

173.63m
ASX:RCE

RECCE PHARMACEUTICALS LTD

Financials

Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of antibiotics. RCE's portfolio of antibiotic therapies seek to address health threats posed by drug resistant bacteria. Their lead candidate RECCE®327 is designed as abroad-spectrum antibiotic, formulated using synthetic polymer technology to treat bacterial sepsis (blood poisoning) and other bacterial infections, including superbugs.

Read more

Market Cap

$203.15m

Price at Close

$1.17

4w avg. Volume

24.73k

4w avg. Turnover

$28.49k

ASX:RCE is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.